Company
Headquarters: Singapore, Singapore
Employees: 12
A$14.5 Million
AUD as of July 1, 2023
US$9.7 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Asian American Medical Group Limited provides specialized medical services for liver diseases in Singapore, rest of Asia, and internationally. It operates through Liver, Multi-Speciality, Management and Consultancy, and Healthcare Real Estate segments. The company provides medical consultation and services for hepatology and related fields; multi-specialty medical consultation and services for medical pilot zones in China; and healthcare management and consultancy services, as well as develops real estate projects. The company was formerly known as Asian Centre for Liver Diseases and Transplantation Limited and changed its name to Asian American Medical Group Limited in December 2012. The company was founded in 1994 and is based in Singapore.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Asian American Medical Group Limited has the following listings and related stock indices.
Stock: ASX: AJJ wb_incandescent